As of April 19, 2025, Jasper Therapeutics (JSPR) has a market cap of $59.638 million USD. According to our data, Jasper Therapeutics is ranked No.7949 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $59.64 M |
-81.41%
|
Dec 31, 2024 | $0.32 B |
170.98%
|
Dec 29, 2023 | $0.12 B |
63.35%
|
Dec 30, 2022 | $72.46 M |
-93.85%
|
Dec 31, 2021 | $1.18 B |
-21.58%
|
Dec 31, 2020 | $1.50 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.53 M |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
-0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.70 B |
0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$52.96 M |
-0.000 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.67 B |
-0.000 M
|
![]() USA
|
Market Cap | = | JSPR Stock Price | * | JSPR Shares Outstanding |
= | $3.97 | * | 15.02 M | |
= | $59.64 M |